Eisai, Biogen (BIIB) Alzheimer drug granted FDA accelerated approval
Go back to Eisai, Biogen (BIIB) Alzheimer drug granted FDA accelerated approval| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 227.53 +2.17 (0.96%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $225.36 | 52 Week High | $333.65 | |||
| Open | $226.94 | 52 Week Low | $223.02 | |||
| Day High | $229.19 | P/E | 29.13 | |||
| Day Low | $222.36 | EPS | $7.81 | |||
| Volume | 1,494,461 | |||||

